Go to top of page
Designated aviation medical examiner's clinical practice guidelines
Date of publication:
19 September 2017
Disclaimer
The clinical practice guidelines is provided by way of guidance only and subject to the clinical practice guidelines disclaimer.
A
- Attention Deficit Hyperactivity Disorder (ADHD)
- Alcohol
- Anticoagulation, Warfarin
- Anticoagulation, Novel Oral Anticoagulants (NOACs)
- Asthma
- Atrial Fibrillation
C
D
- Deep Vein Thrombosis (DVT)
- Depression
- Type 1 Diabetes - Insulin dependent - High risk of hypoglycaemia
- Type 2 Diabetes - Insulin requiring - High risk of hypoglycaemia
- Type 2 Diabetes - Non-insulin dependent - High risk of hypoglycaemia
- Type 2 Diabetes - Non-insulin dependent - Low risk of hypoglycaemia
- ENT (ear, nose, and throat) - Vertigo / Disequilibrium
E
G
H
M
P
S
T
- Transient Global Amnesia (TGA)
- Transient Ischemic Attack (TIA)
- Type 1 Diabetes - Insulin dependent - High risk of hypoglycaemia
- Type 2 Diabetes - Insulin requiring - High risk of hypoglycaemia
- Type 2 Diabetes - Non-insulin dependent - High risk of hypoglycaemia
- Type 2 Diabetes - Non-insulin dependent - Low risk of hypoglycaemia
Last modified: 13 August 2018